Clinical Trials
20 trialsNCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT05417750 2025-12-10
MIZAR-001
Shanghai Juncell Therapeutics
Phase 1 Completed
NCT06716619 2025-03-26
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT06302062 2024-12-03
TAL-T
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT05717699 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT05717712 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT00052884 2023-06-18
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Eastern Cooperative Oncology Group
Phase 1 Terminated
NCT03077477 2018-06-14
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers
Aminex Therapeutics, Inc.
Phase 1 Withdrawn
NCT00238173 2017-04-21
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT00002818 2015-12-14
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies
Virginia Commonwealth University
Phase 1 Completed
NCT00005796 2015-03-25
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Indiana University
Phase 1 Completed
NCT00482846 2014-04-15
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00004036 2013-12-19
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00024310 2013-09-17
Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00003268 2013-08-02
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00002759 2013-02-05
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00317798 2011-08-30
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
University of Rochester
Phase 1 Completed
NCT00003144 2011-03-28
Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
NYU Langone Health
Phase 1 Completed